Snap-8 / Acetyl Octapeptide-3

SNAP-8 (Acetyl Octapeptide-3) is a refined analog of Argireline (Acetyl Hexapeptide-8) representing an extended N-terminal fragment of synaptosomal-associated protein-25 (SNAP-25) — a core component of the SNARE (Soluble NSF Attachment Protein Receptor) complex responsible for neurotransmitter vesicle fusion at the neuromuscular junction. SNAP-8 (Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2) competes with endogenous SNAP-25 for inclusion in the SNARE ternary complex, destabilizing the complex and reducing the efficiency of acetylcholine vesicle exocytosis, thereby attenuating muscle contraction without neurotoxicity. The two additional amino acids in SNAP-8 relative to Argireline confer greater SNARE complex affinity and improved competitive inhibition of vesicle fusion. In vitro binding studies confirm that SNAP-8 occupies the N-terminal SNAP-25 binding site more effectively than the shorter Argireline sequence. Clinical studies using a 10% SNAP-8 solution demonstrated approximately 35% wrinkle depth reduction after 28 days of twice-daily application, compared to approximately 27% for Argireline alone. The mechanism selectively targets dynamic expression wrinkles in high-movement facial zones — forehead, crow's feet, glabellar complex — while preserving baseline muscle tone and facial expression. Unlike botulinum toxin, which cleaves SNAP-25 irreversibly, SNAP-8 acts competitively and reversibly, producing graded, dose-dependent reduction in expression-line formation. Research applications include mechanistic studies of SNARE biology, neuromuscular junction pharmacology, and non-invasive cosmetic wrinkle reduction. SNAP-8 is widely incorporated into anti-wrinkle serums and eye creams at concentrations of 2–10%.